Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $44.6 Million - $56.1 Million
-402,100 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$88.75 - $119.95 $155,135 - $209,672
1,748 Added 0.44%
402,100 $47.7 Million
Q3 2020

Nov 16, 2020

BUY
$75.65 - $93.58 $356,841 - $441,416
4,717 Added 1.19%
400,352 $34.9 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $133,472 - $186,807
1,571 Added 0.4%
395,635 $35.4 Million
Q1 2020

May 15, 2020

BUY
$74.34 - $121.82 $8.44 Million - $13.8 Million
113,478 Added 40.44%
394,064 $39.3 Million
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $123,062 - $139,298
1,076 Added 0.38%
280,586 $32.2 Million
Q3 2019

Nov 14, 2019

SELL
$117.16 - $138.52 $17.7 Million - $21 Million
-151,300 Reduced 35.12%
279,510 $35.3 Million
Q2 2019

Aug 14, 2019

BUY
$81.74 - $120.34 $8.76 Million - $12.9 Million
107,133 Added 33.1%
430,810 $51.8 Million
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $6.45 Million - $7.91 Million
77,429 Added 31.44%
323,677 $28.3 Million
Q4 2018

Feb 14, 2019

BUY
$90.66 - $116.63 $7.01 Million - $9.02 Million
77,319 Added 45.77%
246,248 $24.6 Million
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $35.8 Million - $45.6 Million
-397,860 Reduced 70.2%
168,929 $19.4 Million
Q2 2018

Aug 14, 2018

SELL
$71.53 - $95.75 $26.4 Million - $35.4 Million
-369,507 Reduced 39.46%
566,789 $50.8 Million
Q1 2018

May 15, 2018

SELL
$60.72 - $74.41 $1.61 Million - $1.97 Million
-26,531 Reduced 2.76%
936,296 $68.5 Million
Q4 2017

Feb 14, 2018

BUY
$44.96 - $58.99 $5.72 Million - $7.5 Million
127,193 Added 15.22%
962,827 $55.9 Million
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $33.7 Million - $37.5 Million
835,634
835,634 $37.5 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.26B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Nitorum Capital, L.P. Portfolio

Follow Nitorum Capital, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nitorum Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Nitorum Capital, L.P. with notifications on news.